No records found.
To search for expired listings or expired news releases please visit www.LexisNexis.com
 

	Date		Title
	02/02/2015		Section 101 at the AIPLA Midwinter Meeting
	01/27/2015		Myriad Settles – Questions Remain
	01/21/2015		TEVA v. SANDOZ – THE DISSENT AND THE ZONE OF UNCERTAINTY
	01/21/2015		Teva v. Sandoz: “Just the facts, Ma’am”
	01/20/2015		Promega v. Life Technologies – “Too Much Of Nothing?”
	01/05/2015		Chisum Patent Academy Close To Full
	12/30/2014		The “Top Ten” IP Stories of 2014 (Most “Definitely”)
	12/18/2014		Mayo Meet Alice Meet Myriad – Fed. Cir. Appreciates “Abstract Art”
	12/16/2014		Revised 2014 Interim Guidance on Patent Subject Matter Eligibility Released b...
	12/12/2014		Supreme Court to Review Post-Expiration Date Royalties in Kimble v. Marvell
	12/08/2014		Commil USA v. Cisco Systems – Induced Infringement In For Clarification
	11/14/2014		Federal Circuit flips on Ultramercial v. WildTangent
	11/13/2014		C.I.T. v. Hughes Comm. – Survival Guide for Software?
	11/05/2014		Genetic Technologies v. Bristol Myers – 101 At Work
	11/03/2014		Canadian Hospital To Travel The Long And Winding Road Of “Gene Patenting”
	11/01/2014		AIPLA Announces New Executive Director
	10/09/2014		EPO – New Guidance On Added Subject Matter
	09/30/2014		American Calcar v. Amer. Honda Motor Co. – Therasense Goes Out For a Test Drive
	09/29/2014		PLANET BLUE v. NAMCO – Abstract at the “Point of Novelty”
	09/16/2014		Genetic Technologies v. LabCorp. – Mayo Redux.
	09/12/2014		SLW Smashes 101 Rejections
	09/11/2014		FDA Publishes “Purple Book” for Biologicals/Biosimilars
	09/05/2014		Australia: Cancer Voices v Myriad Opinion Affirmed
	09/04/2014		101 Rejections Under the Guidelines: Mayo and Myriad “Go Viral”